North China Pharmaceutical Company.Ltd Balance Sheet Health
Financial Health criteria checks 1/6
North China Pharmaceutical Company.Ltd has a total shareholder equity of CN¥6.3B and total debt of CN¥10.7B, which brings its debt-to-equity ratio to 170.2%. Its total assets and total liabilities are CN¥20.9B and CN¥14.6B respectively. North China Pharmaceutical Company.Ltd's EBIT is CN¥530.4M making its interest coverage ratio 1.3. It has cash and short-term investments of CN¥869.7M.
Key information
170.2%
Debt to equity ratio
CN¥10.73b
Debt
| Interest coverage ratio | 1.3x |
| Cash | CN¥869.70m |
| Equity | CN¥6.30b |
| Total liabilities | CN¥14.57b |
| Total assets | CN¥20.88b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 600812's short term assets (CN¥7.9B) do not cover its short term liabilities (CN¥9.8B).
Long Term Liabilities: 600812's short term assets (CN¥7.9B) exceed its long term liabilities (CN¥4.8B).
Debt to Equity History and Analysis
Debt Level: 600812's net debt to equity ratio (156.4%) is considered high.
Reducing Debt: 600812's debt to equity ratio has increased from 166% to 170.2% over the past 5 years.
Debt Coverage: 600812's debt is not well covered by operating cash flow (13.1%).
Interest Coverage: 600812's interest payments on its debt are not well covered by EBIT (1.3x coverage).